Your browser doesn't support javascript.
loading
MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG).
Siu, Ho Wai Derrick; Tebbutt, Niall; Chantrill, Lorraine; Karapetis, Chris; Steer, Christopher; Wilson, Kate; Espinoza, David; Bailey, Lisa; Yip, Sonia; Cuff, Jeff; Pavlakis, Nick; Thavaneswaran, Subotheni; Briscoe, Karen; Srivastav, Ratnesh; Shannon, Jennifer; Segelov, Eva; Tie, Jeannie; Caird, Susan; Francesconi, Alessandra; Price, Timothy; Wuttke, Melanie; Ladwa, Rahul; Sjoquist, Katrin; Burge, Matthew.
  • Siu HWD; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia. monarcc@ctc.usyd.edu.au.
  • Tebbutt N; , Camperdown, Australia. monarcc@ctc.usyd.edu.au.
  • Chantrill L; Austin Hospital, Melbourne, Australia.
  • Karapetis C; Shoalhaven Cancer Care Centre, Nowra, Australia.
  • Steer C; Flinders Medical Centre, Adelaide, Australia.
  • Wilson K; Border Medical Oncology Research Unit, Albury-Wodonga, Australia.
  • Espinoza D; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
  • Bailey L; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
  • Yip S; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
  • Cuff J; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
  • Pavlakis N; Australasian Gastrointestinal Group (AGITG), Sydney, Australia.
  • Thavaneswaran S; Northern Cancer Institute, Sydney, Australia.
  • Briscoe K; St Vincent's Public Hospital, Sydney, Australia.
  • Srivastav R; Coffs Harbour Health Campus, Coffs Harbour, Australia.
  • Shannon J; The Tweed Hospital, Tweed Heads, Australia.
  • Segelov E; Nepean Hospital, Sydney, Australia.
  • Tie J; Monash Medical Centre, Melbourne, Australia.
  • Caird S; Sunshine Hospital, Melbourne, Australia.
  • Francesconi A; Gold Coast University Hospital, Gold Coast, Australia.
  • Price T; Sunshine Coast University Hospital, Sunshine Coast, Australia.
  • Wuttke M; The Queen Elizabeth Hospital, Adelaide, Australia.
  • Ladwa R; Royal Hobart Hospital, Hobart, Australia.
  • Sjoquist K; Princess Alexandra Hospital, Brisbane, Australia.
  • Burge M; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
BMC Cancer ; 21(1): 932, 2021 Aug 18.
Article en En | MEDLINE | ID: mdl-34407800
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas ras / Proteínas Proto-Oncogénicas B-raf / Mutación Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas ras / Proteínas Proto-Oncogénicas B-raf / Mutación Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article